US equities |
NVDA $241.66 ▲+1.16% SPCX $173.84 ▲+1.60% MU $1,064.80 ▲+0.08% AMD $655.34 ▲+3.73% MRVL $285.92 ▲+5.41% SNDK $1,673.58 ▼-1.79% AVGO $378.59 ▲+4.44% TSLA $380.48 ▲+0.46%
FinancialContent

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

17.45 -0.37 (-2.05%)
Delayed Quote Updated: 12:06 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PROCEPT BioRobotics Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
Law Offices of Frank R. Cruz Encourages PROCEPT BioRobotics Corporation (PRCT) Shareholders To Inquire About Securities Fraud Class Action
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Cogent Communications Holdings, Inc. (NASDAQ: CCOI); EquipmentShare.com, Inc. (NASDAQ: EQPT); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law
From Grabar Law Office
Via GlobeNewswire
News headline image
PRCT Shareholder Alert: PROCEPT BIOROBOTICS CORPORATION Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
Deadline Approaching: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
PRCT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 29, 2026) - Kahn Swick & Foti, LLC ("KSF")... 
Via Newsfile
Topics Fraud Lawsuit
News headline image
PROCEPT BIOROBOTICS CORPORATION INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 22, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
PROCEPT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against PROCEPT BioRobotics Corporation and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
PRCT Lawsuit Alert: PROCEPT BioRobotics Corp. Sued for Securities Fraud after that Undisclosed Discount Program Allegations Lead to 18% Stock Drop – Investors Notified to Contact BFA Law
From Bleichmar Fonti & Auld LLP
Via Business Wire
News headline image
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages PROCEPT BioRobotics Corporation (PRCT) Shareholders To Inquire About Securities Fraud Class Action
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
INVESTOR ALERT: Securities Class Action Filed Against PROCEPT BioRobotics Corporation – Investors Encouraged to Contact Kirby McInerney LLP
From Kirby McInerney LLP
Via Business Wire
News headline image
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Law Offices of Howard G. Smith Encourages PROCEPT BioRobotics Corporation (PRCT) Shareholders To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Notice to Long-Term Shareholders of Cogent Communications Holdings, Inc. (NASDAQ: CCOI); EquipmentShare.com, Inc. (NASDAQ: EQPT); Photronics, Inc. (NASDAQ: PLAB); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating
From Grabar Law Office
Via GlobeNewswire
News headline image
PROCEPT BIOROBOTICS CORPORATION (PRCT) INVESTOR ALERT Investors With Large Losses in PROCEPT BioRobotics Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – PRCT
From The DJS Law Group
Via Business Wire
News headline image
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses
From Robbins LLP
Via Business Wire
News headline image
Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors
From Mobia Medical, Inc.
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch ↗
Biotech firm Nektar Therapeutics advances a pipeline of immunology and oncology candidates through research-driven collaborations. 
Via The Motley Fool
News headline image
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% ↗
GeneDx Holdings delivers AI-powered clinical and genomic data analysis for healthcare providers seeking precision medicine solutions. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
5 Robotics Stocks to Watch as Physical AI Builds Momentum ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
AUA Guidelines Strengthen Recommendation for Aquablation® Therapy
Update reflects growing clinical evidence and expanded adoption in practice 
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
Procept (PRCT) Q1 2026 Earnings Transcript ↗
Procept (PRCT) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >